Literature DB >> 21293295

Neuronal-astrocyte metabolic interactions: understanding the transition into abnormal astrocytoma metabolism.

Dennis A Turner1, David Cory Adamson.   

Abstract

Brain function depends on complex metabolic interactions among only a few different cell types, with astrocytes providing critical support for neurons. Astrocyte functions include buffering the extracellular space, providing substrates to neurons, interchanging glutamate and glutamine for synaptic transmission with neurons, and facilitating access to blood vessels. Whereas neurons possess highly oxidative metabolism and easily succumb to ischemia, astrocytes rely more on glycolytic metabolism and hence are less susceptible tolack of oxygen. Astrocytoma cells seem to retain basic metabolic mechanisms of astrocytes; for example, they show a high glycolytic rate, lactate extrusion, ability to flourish under hypoxia, and opportunistic use of mechanisms to enhance cell division and maintain growth. Differences in metabolism between neurons and astrocytes may also extend to astrocytoma cells, providing therapeutic opportunities against astrocytomas, including sensitivity to acetate, a high rate of glycolysis and lactate extrusion, glutamate uptake transporters, differential sensitivities of monocarboxylate transporters, presence of glycogen, high interlinking with gap junctions, use of nicotinamide adenine dinucleotide phosphate for lipid synthesis, using different isoforms of synthetic enzymes (e.g. isocitrate dehydrogenase, pyruvate carboxylase, pyruvate kinase, lactate dehydrogenase), and different glucose uptake mechanisms. These unique metabolic susceptibilities may augment conventional therapeutic attacks based on cell division differences and surface receptors alone.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21293295      PMCID: PMC3045672          DOI: 10.1097/NEN.0b013e31820e1152

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  80 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  The oxygen sensing signal cascade under the influence of reactive oxygen species.

Authors:  Helmut Acker
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

3.  Cancer. Puzzling patterns of predisposition.

Authors:  Patrick J Pollard; Peter J Ratcliffe
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

4.  Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis.

Authors:  Marie E Beckner; Glenn T Gobbel; Roger Abounader; Fatima Burovic; Naomi R Agostino; John Laterra; Ian F Pollack
Journal:  Lab Invest       Date:  2005-12       Impact factor: 5.662

5.  Gliomas are driven by glycolysis: putative roles of hexokinase, oxidative phosphorylation and mitochondrial ultrastructure.

Authors:  S Oudard; E Boitier; L Miccoli; S Rousset; B Dutrillaux; M F Poupon
Journal:  Anticancer Res       Date:  1997 May-Jun       Impact factor: 2.480

6.  Feasibility of imaging pentose cycle glucose metabolism in gliomas with PET: studies in rat brain tumor models.

Authors:  A M Spence; M M Graham; M Muzi; S D Freeman; J M Link; J R Grierson; F O'Sullivan; D Stein; G L Abbott; K A Krohn
Journal:  J Nucl Med       Date:  1997-04       Impact factor: 10.057

7.  The expression and significance of HIF-1alpha and GLUT-3 in glioma.

Authors:  Yang Liu; Yun-ming Li; Rui-feng Tian; Wei-ping Liu; Zhou Fei; Qian-fa Long; Xiao-an Wang; Xiang Zhang
Journal:  Brain Res       Date:  2009-09-25       Impact factor: 3.252

8.  Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha.

Authors:  Shimin Zhao; Yan Lin; Wei Xu; Wenqing Jiang; Zhengyu Zha; Pu Wang; Wei Yu; Zhiqiang Li; Lingling Gong; Yingjie Peng; Jianping Ding; Qunying Lei; Kun-Liang Guan; Yue Xiong
Journal:  Science       Date:  2009-04-10       Impact factor: 47.728

9.  Lactate promotes glioma migration by TGF-beta2-dependent regulation of matrix metalloproteinase-2.

Authors:  Fusun Baumann; Petra Leukel; Anett Doerfelt; Christoph P Beier; Katja Dettmer; Peter J Oefner; Michael Kastenberger; Marina Kreutz; Thomas Nickl-Jockschat; Ulrich Bogdahn; Anja-Katrin Bosserhoff; Peter Hau
Journal:  Neuro Oncol       Date:  2008-11-25       Impact factor: 12.300

10.  Lactate uptake contributes to the NAD(P)H biphasic response and tissue oxygen response during synaptic stimulation in area CA1 of rat hippocampal slices.

Authors:  Francesca Galeffi; Kelley A Foster; Matthew P Sadgrove; Christopher J Beaver; Dennis A Turner
Journal:  J Neurochem       Date:  2007-10-10       Impact factor: 5.372

View more
  42 in total

1.  Protective effects of carbenoxolone are associated with attenuation of oxidative stress in ischemic brain injury.

Authors:  Lang Zhang; Yu-Min Li; Yu-Hong Jing; Shao-Yu Wang; Yan-Feng Song; Jie Yin
Journal:  Neurosci Bull       Date:  2013-05-07       Impact factor: 5.203

Review 2.  Pathophysiology and neuroprotection of global and focal perinatal brain injury: lessons from animal models.

Authors:  Luigi Titomanlio; David Fernández-López; Lucilla Manganozzi; Raffaella Moretti; Zinaida S Vexler; Pierre Gressens
Journal:  Pediatr Neurol       Date:  2015-01-31       Impact factor: 3.372

3.  Negative regulation of human astrocytes by interferon (IFN) α in relation to growth inhibition and impaired glucose utilization.

Authors:  Ting Wang; Yasuhiro Takikawa; Kei Sawara; Yuichi Yoshida; Kazuyuki Suzuki
Journal:  Neurochem Res       Date:  2012-05-25       Impact factor: 3.996

4.  Hyperpolarized 13C pyruvate mouse brain metabolism with absorptive-mode EPSI at 1T.

Authors:  Vesselin Z Miloushev; Valentina Di Gialleonardo; Lucia Salamanca-Cardona; Fabian Correa; Kristin L Granlund; Kayvan R Keshari
Journal:  J Magn Reson       Date:  2016-12-21       Impact factor: 2.229

Review 5.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

6.  Selective expression of eGFP in mouse perivascular astrocytes by modification of the Mlc1 gene using T2A-based ribosome skipping.

Authors:  Jordan J Toutounchian; Joseph H McCarty
Journal:  Genesis       Date:  2017-10-06       Impact factor: 2.487

7.  The PPARγ agonist rosiglitazone prevents cognitive impairment by inhibiting astrocyte activation and oxidative stress following pilocarpine-induced status epilepticus.

Authors:  Sun Hong; Yu Xin; Wu HaiQin; Zhang GuiLian; Zhang Ru; Zhan ShuQin; Wang HuQing; Yao Li; Du Yun
Journal:  Neurol Sci       Date:  2011-09-14       Impact factor: 3.307

Review 8.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

9.  Decreased astroglial monocarboxylate transporter 4 expression in temporal lobe epilepsy.

Authors:  Bei Liu; Le Niu; Ming-Zhi Shen; Lei Gao; Chao Wang; Jie Li; Li-Jia Song; Ye Tao; Qiang Meng; Qian-Li Yang; Guo-Dong Gao; Hua Zhang
Journal:  Mol Neurobiol       Date:  2014-01-25       Impact factor: 5.590

Review 10.  The biology and mathematical modelling of glioma invasion: a review.

Authors:  J C L Alfonso; K Talkenberger; M Seifert; B Klink; A Hawkins-Daarud; K R Swanson; H Hatzikirou; A Deutsch
Journal:  J R Soc Interface       Date:  2017-11       Impact factor: 4.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.